CellCarta Secures Exclusive Global Rights to Deploy Aspyre Lung Assay in Lung Cancer Clinical Trials

The multi-year partnership grants CellCarta exclusive rights to deploy Biofidelity’s Aspyre Lung assay in clinical trial settings worldwide.Read More